Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. Operating Income 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Connect Biopharma Holdings Ltd. operating income for the quarter ending March 31, 2026 was -19.6 M, a 71.29% increase year-over-year.
- Connect Biopharma Holdings Ltd. operating income for the twelve months ending March 31, 2026 was -62.2 M.
- Connect Biopharma Holdings Ltd. annual operating income for 2025 was -58.1 M, a 158.66% increase from 2024.
- Connect Biopharma Holdings Ltd. annual operating income for 2024 was -22.5 M, a 67.49% decrease from 2023.
- Connect Biopharma Holdings Ltd. annual operating income for 2023 was -69.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Connect Biopharma Holdings Ltd. Operating Income — FAQ
Connect Biopharma Holdings Ltd. (CNTB) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Connect Biopharma Holdings Ltd.'s operating income?
Connect Biopharma Holdings Ltd. (CNTB) reported operating income of -$58M for fiscal 2025.
Where can I see CNTB's operating income history?
The chart and table above show Connect Biopharma Holdings Ltd.'s operating income by year and by quarter, including the growth rate.